Abstract
This is the fourth reported case of central diabetes insipidus with oligohydramnios. Central diabetes insipidus does not adversely affect pregnancy; it can present with oligohydramnios, which can be improved by treating central diabetes insipidus.
Keywords: diabetes insipidus, oligohydramnios, pregnancy
This is the fourth reported case of central diabetes insipidus with oligohydramnios. Central diabetes insipidus does not adversely affect pregnancy; it can present with oligohydramnios, which can be improved by treating central diabetes insipidus.

1. INTRODUCTION
Maternal diabetes insipidus does not usually adversely affect the course of pregnancy. We present a rare case of central diabetes insipidus diagnosed at 31 weeks of gestation with fetal oligohydramnios successfully treated with intranasal desmopressin. To date, only three cases of diabetes insipidus with oligohydramnios have been reported.
Central diabetes insipidus is a rare endocrine disease with predominant symptoms of polydipsia and polyuria. It has been shown that central diabetes insipidus does not affect the course of pregnancy; however, a few cases complicated by oligohydramnios have been reported. Herein, we report a case of central diabetes insipidus with oligohydramnios, the fourth of such case ever reported.
2. CASE PRESENTATION
2.1. Case history and examination
The patient was a 30‐year‐old primigravida who was 168 cm tall and weighed 50 kg, without a significant medical history. She was not taking any medication, and there was no significant family history. There were no high‐risk social factors. She was managed at a nearby maternity clinic from the start of her pregnancy. The pregnancy progressed without any particular problems; however, at 31 weeks and 4 days of gestation, an amniotic fluid index (AFI) of 0 was identified during a prenatal check‐up. The biophysical profile of the fetus was favorable except for oligohydramnios. The patient was hospitalized at the clinic and hydrated with 2000 ml/day intravenously to increase her amniotic fluid volume.
Additionally, the medical staff noted that she drank large amounts of water (4000–6000 ml/day) during hospitalization and had experienced severe thirst before her pregnancy. This symptom is indicative of an endocrine disorder; hence, she was referred to our institution and hospitalized at 32 weeks of gestation.
2.2. Investigations
We identified polydipsia and hypotonic polyuria using urine specific gravity (1.001), urine osmolarity (51 mOsm/kgH20), and serum osmolarity (281 mOsm/kgH20). The estimated fetal weight and amniotic fluid volume were 2107 g (+1.39 standard deviation) and AFI 4, respectively. The daily urine volume exceeded 7000 ml. On the day of her first visit, her vasopressin level was 0.4 pg/ml under free drinking water. The changes in the daily urine volume, plasma and urine osmolarity, serum sodium level, and AFI of the patient are shown in Figure 1. On plain MRI, there was no evidence of neoplastic lesions in the pituitary gland, and no enlargement of the pituitary gland and stalk. On T1‐weighted imaging, the absence of a bright spot suggestive of vasopressin retention in the posterior lobe was considered to be suggestive of central DI (Figure 2). We carefully conducted a water deprivation test at 32 weeks and 4 days of pregnancy while monitoring the fetus and mother; she soon complained of unbearable thirst and urinated about 1500 ml within 4 hours of the start of the test, at which point a blood sample was taken showing a Na level of 149 mEq/L. Further testing was stopped due to risks such as uteroplacental insufficiency. No increase in urine osmolarity was noted during this test (67to 76 mOsm/kgH20 in the 4 hours).
FIGURE 1.

Changes in the daily urine volume, plasma and urine osmolarity, serum sodium level, and AFI
FIGURE 2.

Plain head MRI (T1‐weighted image) at 32 weeks gestation
2.3. Differential diagnosis and treatment
This case is novel in that the diagnosis of diabetes insipidus was made on the basis of oligohydramnios. Oligohydramnios is usually associated with fetal diseases such as fetal circulatory failure and renal disease, when preterm prelabor rupture of membranes is excluded, and with maternal causes such as hypertensive disorders during pregnancy and the use of certain medications. Amniotic fluid volume is a crucial factor in assessing the wellbeing of the fetus; if severe oligohydramnios is observed, as in this case, we need to consider whether early delivery of the fetus is warranted. In this case, careful observation determined that immediate delivery of the fetus was not necessary, and maternal hydration, which is known to be effective against isolated oligohydramnios, was instituted.1 Hospitalization for this purpose led to the diagnosis of diabetes insipidus in the patient. In cases of suspected diabetes insipidus, it is critical to differentiate between psychogenic polydipsia, central diabetes insipidus, renal diabetes insipidus, and transient diabetes insipidus of pregnancy.
DI can be central or renal, and in pregnancy, transient DI is associated with elevated placental vasopressinase, which is also associated with the development of preeclampsia; therefore, it is important to differentiate between these conditions.2 Results were consistent with central diabetes insipidus; thus, we started transnasal administration of desmopressin. We noted reduced water intake and urinary volume after the initiation of desmopressin, along with increased amniotic fluid volume (AFI 12). The patient was discharged at 33 weeks and 6 days of pregnancy, and the subsequent amniotic fluid volume was well maintained (AFI 9–16). She had a spontaneous rupture of the membrane at 38 weeks and 5 days of gestation and had vaginal delivery of a baby boy (3,434 g). The infant had an umbilical cord blood gas of pH 7.380 and an Apgar score of 8 points at 1 minute and 10 points at 5 minutes. The infant remained in good condition.
2.4. Outcome and follow‐up
A magnetic resonance imaging scan of the patient's head taken during her 1‐month postpartum check‐up showed similar results to that taken during pregnancy; thus, it was suggested that central diabetes insipidus may have existed even before the pregnancy. Gadolinium‐based contrast agents have very little effect on the infant during breastfeeding, but she preferred plain MRI. At the time of this article's publication, the patient had continued to receive desmopressin treatment at a local institution for about 8 months. She is breastfeeding well. To date, there has been no attempt to differentiate between other diseases presenting with central DI, but based on family history, laboratory history, and imaging findings, idiopathic central DI is the most likely cause.
3. DISCUSSION
Although cases of gestational diabetes insipidus with oligohydramnios, such as the present case, are rare, they have been recorded in the literature, and three cases have demonstrated improvement in amniotic fluid volume with desmopressin treatment.3, 4, 5 Table 1 shows the treatment course for each case. The mechanism as to how diabetes insipidus reduces amniotic fluid volume remains unknown. However, in a report on the relationship between changes in maternal and fetal plasma osmolality, it was described that the increase in maternal plasma osmolality was accompanied by an increase in fetal plasma osmolality. This suggests that fetal urine production may be affected by changes in plasma osmolality.6, 7 This potentially play a role in suppressing fetal urine production. In terms of water movement through fetal membranes, it has been reported that membrane permeability increases with gestational age and that membrane water flow can be changed by both hydrostatic and osmotic forces.8 Although there have been studies on the increased permeability of amniotic fluid to the maternal side due to overexpression of aquaporin 1 and 3, there have been no studies specific to diabetes insipidus, and further studies are needed.9, 10 Although the majority of previous studies suggest that diabetes insipidus does not adversely affect the course of pregnancy, this report increases the number of cases of oligohydramnios associated with diabetes insipidus and should contribute to future studies on pregnancies with this condition.11, 12, 13 Oligohydramnios may be used to diagnose central diabetes insipidus, as was shown in the present case. Moreover, we demonstrated that oligohydramnios with central diabetes insipidus may be treated by the administration of desmopressin.
TABLE 1.
Cases of diabetes insipidus that presented with oligohydramnios
| Author | Year | Age | Parity | Medical history | Symptoms | Cause | Delivery weeks/days | Delivery | Clinical course |
|---|---|---|---|---|---|---|---|---|---|
| Hanson RS et al.3 | 1997 | 14 | 0 | None | Uterine contraction, genital bleeding, edema | Pituitary dysplasia | 38 weeks | Transvaginal | Good |
| Park JW et al.4 | 2017 | 30 | 0 | None | Anorexia | Idiopathic central DIa | 37 weeks | Cesarean section | Good |
| Choi HS et al.5 | 2018 | 37 | 0 | None | Thirstiness, polyuria | Rathke's cleft cyst | 37 weeks 4 days | Cesarean section | Good |
| Imaizumi K et al. | 30 | 0 | None | Thirstiness, polyuria | Idiopathic central DIa | 38 weeks 5 days | Transvaginal | Good |
Diabetes insipidus.
CONFLICTS OF INTEREST
The authors report no conflicts of interest.
AUTHOR CONTRIBUTIONS
Karin Imaizumi: Writing the paper. Shun Yasuda: Corresponding author, Idea or design of the study. Naoya Toba, Takayuki Okazaki, Toma Fukuda, Tsuyoshi Murata, Aya Kanno, Hyo Kyozuka, Makiho Ishibashi, Fumihiro Ito: Critical revision of the paper. Akiko Yamaguchi, Keiya Fujimori: Approval of the final draft.
ETHICAL APPROVAL
This study was approved by the Ethics Committee of Iwase General Hospital (#191103).
ACKNOWLEDGMENTS
We would like to express our gratitude to Dr. Shinichi Oda and Dr. Kenichi Sato of the Department of Pediatrics, Iwase General Hospital, for taking care of the infant; Dr. Masahiro Ohta of Ohta Medical Clinic, Sukagawa City, Japan, for the treatment of diabetes insipidus; and all the staff who were involved in the treatment of our patient. Published with written consent of the patient.
Imaizumi K, Yasuda S, Toba N, et al. Pregnancy complicated by central diabetes insipidus and oligohydramnios. Clin Case Rep. 2021;9:e04590. 10.1002/ccr3.4590
DATA AVAILABILITY STATEMENT
The authors confirm that the data supporting the findings of the study are available within the article.
REFERENCES
- 1.Gizzo S, Noventa M, Vitagliano A, et al. An update on maternal hydration strategies for amniotic fluid improvement in isolated oligohydramnios and normohydramni os: evidence from a systematic review of literature and meta‐analysis. PLoS One. 2015;10(12):e0144334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Del Carpio‐Orantes L. Transient central diabetes insipidus associated with pregnancy: Case report and bibliography review. (In Spanish.). Rev Med Inst Mex Seguro Soc. 2017;55:672‐675. [PubMed] [Google Scholar]
- 3.Hanson RS, Powrie RO, Larson L. Diabetes insipidus in pregnancy: a treatable cause of oligohydramnios. Obstet Gynecol. 1997;89(5 Pt 2):816‐817. [DOI] [PubMed] [Google Scholar]
- 4.Park JW, Park HY, Hwang YJ, Han SY. A case of gestational central diabetes insipidus with oligohydramnios. J Obstet Gynaecol. 2018;38(1):135‐136. [DOI] [PubMed] [Google Scholar]
- 5.Choi HS, Kim YH, Kim CS, Ma SK, Kim SW, Bae EH. Diabetes insipidus presenting with oligohydramnios and polyuria during pregnancy. J Nippon Med Sch. 2018;85(3):191‐193. [DOI] [PubMed] [Google Scholar]
- 6.Ladella SJ, Desai M, Cho Y, Ross MG. Maternal plasma hypertonicity is accentuated in the postterm rat. Am J Obstet Gynecol. 2003;189(5):1439‐1444. [DOI] [PubMed] [Google Scholar]
- 7.Desai M, Ladella S, Ross MG. Reversal of pregnancy‐mediated plasma hypotonicity in the near‐term rat. J Matern Fetal Neonatal Med. 2003;13(3):197‐202. [DOI] [PubMed] [Google Scholar]
- 8.Beall MH, van den Wijngaard JP, van Gemert MJ, Ross MG. Amniotic fluid water dynamics. Placenta. 2007;28(8–9):816‐823. [DOI] [PubMed] [Google Scholar]
- 9.Zhu XQ, Jiang SS, Zhu XJ, Zou SW, Wang YH, Hu YC. Expression of aquaporin 1 and aquaporin 3 in fetal membranes and placenta in human term pregnancies with oligohydramnios. Placenta. 2009;30(8):670‐676. [DOI] [PubMed] [Google Scholar]
- 10.Martínez N, Damiano AE. Aquaporins in fetal development. Adv Exp Med Biol. 2017;969:199‐212. [DOI] [PubMed] [Google Scholar]
- 11.Brewster UC, Hayslett JP. Diabetes insipidus in the third trimester of pregnancy. Obstet Gynecol. 2005;105(5 Pt 2):1173‐1176. [DOI] [PubMed] [Google Scholar]
- 12.Adonakis G, Kyriazopoulou V, Androutsopoulos G, Papadopoulos VG, Decavalas GO, Georgopoulos NA. Diabetes insipidus and two consecutive pregnancies: a case report and review of the literature. Clin Exp Obstet Gyn. 2011;38(3):301‐302. [PubMed] [Google Scholar]
- 13.Ananthakrishnan S. Diabetes insipidus in pregnancy: etiology, evaluation, and management. Endocr Pract. 2009;15(4):377‐382. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The authors confirm that the data supporting the findings of the study are available within the article.
